Latest Ian Read Stories
Pfizer said Europe is undermining drug innovation by cutting prices, raising barriers to new medicines and "freeloading" off others in Asia and the U.S. who are willing to pay.
Ian Read, President and Chief Executive Officer, Pfizer Jerzy Gruhn, President, Novo Nordisk Inc. Mark Iwicki, President and Chief Operating Officer, Sunovion Pharmaceuticals Inc. Staffan Schuberg, President, Lundbeck Inc. WASHINGTON, Dec.
NEW YORK, Dec. 5, 2010 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) today announced that its Board of Directors has elected Ian C. Read, 57, currently head of the Company's global biopharmaceutical operations, as President, Chief Executive Officer and Director. Mr. Read succeeds Jeffrey B.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).